ArticleInternational urology and nephrology2022
Long COVID and COVID-19-associated cystitis (CAC).
Article in International urology and nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.
- Unveiling the genitourinary phenotype of long COVID: a systematic review and meta-analysis.International urology and nephrology · 2026Pooled it
- The genitourinary phenotype of COVID: a personal perspective.International urology and nephrology · 2026Article
- Changes in Uropathogen Distribution in Relation to the COVID-19 Pandemic Timeline.International urogynecology journal · 2026Article
- Article
- Prevalence and Phenotype of Lower Urinary Tract Symptoms in Fibromyalgia: A Retrospective Observational Study at a Single Tertiary Medical Center.Journal of clinical medicine · 2025Article
- Therapeutic efficacy and short-term durability of trans-urethral amniotic bladder injections for the treatment of refractory COVID-associated cystitis.Bladder (San Francisco, Calif.) · 2024Article
- Prolonged urinary retention in COVID-19 survivors: observational study.Revista da Associacao Medica Brasileira (1992) · 2024Observational
- Spinal cord infarction attributed to SARS-CoV-2, with post-acute sequelae of COVID-19: A case report.World journal of clinical cases · 2023Article
- Prolonged impacts of COVID-19-associated cystitis: A study on long-term consequences.World journal of clinical cases · 2023Article
- COVID-associated cystitis: the culprit behind the bladder woes post-COVID infection? A review.International urology and nephrology · 2023Review
- The effectiveness of COVID deaths to COVID policies: A robust conditional approach.Economic analysis and policy · 2023Article
- Clinico-epidemiological profile and outcome of infected health care workers during the three consecutive waves of COVID-19 pandemic: a longitudinal cohort study.Therapeutic advances in vaccines and immunotherapy · 2023Article
- Prescription of Choreito, a Japanese Kampo Medicine, with Antimicrobials for Treatment of Acute Cystitis: A Retrospective Cohort Study.Antibiotics (Basel, Switzerland) · 2022Article
- The Lancet Commission on lessons for the future from the COVID-19 pandemic.Lancet (London, England) · 2022Review
- Impact of COVID-19 on male urogenital health: Success of vaccines.Drug discovery today · 2022Review
- 581 UROLOGICAL SYMPTOMS IN PATIENTS WITH COVID-19: EXPLORING CHANGES IN FREQUENCY BY PANDEMIC WAVES.Continence (Amsterdam, Netherlands) · 2022Article
- The Pathophysiology of Long COVID throughout the Renin-Angiotensin System.Molecules (Basel, Switzerland) · 2022Review
- Covid-19, pelvic health, and women's voices: A descriptive study.Continence (Amsterdam, Netherlands) · 2022Article
Corrections and comments
- Commented on byGeriatrics.2022
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThere is scarce literature regarding genitourinary symptoms in COVID-19, especially post-acute disease otherwise known as Long COVID. We identified recovered COVID-19 patients presenting with new or worsening overactive bladder symptoms, known as COVID-19-associated cystitis (CAC).
methodsWe used the American Urological Association Urology Care Foundation Overactive Bladder (OAB) Assessment Tool to screen COVID-19 recovered patients presenting with urological complaints at our urban-located institution from 5/22/2020 to 12/31/2020. Patients 10-14 weeks post-discharge responded to 5 symptom and 4 quality-of-life (QoL) questions. We reported median symptom scores, as well as QoL scores, based on new or worsening urinary symptoms, and by sex.
resultsWe identified 350 patients with de novo or worsening OAB symptoms 10-14 weeks after hospitalization with COVID-19. The median total OAB symptom score in both men and women was 18. The median total QoL score for both men and women was 19. Patients with worsening OAB symptoms had a median pre-COVID-19 symptom score of 8 (4-10) compared to post-COVID-19 median symptom score of 19 (17-21). Median age was 64.5 (range 47-82). Median hospital length-of-stay was 10 days (range 5-30).
conclusionWe report survey-based results of patients suffering from new or worsening OAB symptoms months after their hospitalization from COVID-19. Future studies with larger sample sizes and more extensive testing will hopefully elucidate the specific pathophysiology of OAB symptoms in the context of long COVID so urologists can timely and appropriately treat their patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.